Red blood cell transfusion therapy for sickle cell patients with frequent painful events-Reference-Cited by-同舟云学术

Red blood cell transfusion therapy for sickle cell patients with frequent painful events

Published:2018-08-27 Issue:12 Volume:65 Page:e27423
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hilliard Lee M.¹,Kulkarni Varsha¹,Sen Bisakha²,Caldwell Cathy³,Bemrich-Stolz Christina¹,Howard Thomas H.¹,Brandow Amanda⁴,Waite Emily¹,Lebensburger Jeffrey D.¹^ORCID

Affiliation:

1. Division of Pediatric Hematology Oncology; The University of Alabama at Birmingham; Birmingham Alabama

2. Department of Health Care Organization and Policy; The University of Alabama at Birmingham; Birmingham Alabama

3. Alabama Department of Public Health; Montgomery Alabama

4. Division of Pediatric Hematology Oncology; Medical College of Wisconsin; Milwaukee Wisconsin

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27423/fullpdf

Reference19 articles.

1. Daily home opioid use in adults with sickle cell disease: the PiSCES project;Smith;J Opioid Manag,2015

2. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea;Stettler;JAMA,2015

3. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy;Estepp;Am J Hematol,2017

4. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy;Ware;Blood,2002

5. Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use;Green;Pediatr Blood Cancer,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Delayed Transfusion Reactions in Sickle Cell Disease Patients Polytransfused in the Brazilian Amazon;Hematology Reports;2024-08-01

2. Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges — review article;Annals of Hematology;2023-10-23

3. Global burden of transfusion in sickle cell disease;Transfusion and Apheresis Science;2023-07

4. SCD-CARRE: Monthly Red Blood Cell Exchange Transfusions for Individuals Living With High-risk Sickle Cell Disease;The Hematologist;2023

5. Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease;Journal of Clinical Apheresis;2022-09-29